Login / Signup

Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.

Murilo GuedesDaniel G MuenzJarcy ZeeBrian A BieberBenedicte StengelZiad A MassyNicolas MansencalMichelle M Y WongDavid M CharytanHelmut ReichelSandra WaechterRonald L PisoniBruce M RobinsonRoberto Pecoits-Filhonull null
Published in: Journal of the American Society of Nephrology : JASN (2021)
Iron deficiency, as captured by TSAT, is associated with higher risk of all-cause mortality and MACE in patients with nondialysis CKD, with or without anemia. Interventional studies evaluating the effect on clinical outcomes of iron supplementation and therapies for alternative targets are needed to better inform strategies for administering exogenous iron.
Keyphrases
  • iron deficiency
  • cardiovascular events
  • chronic kidney disease
  • coronary artery disease
  • cardiovascular disease
  • type diabetes